RecruitingPhase 1/2

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

United States200 participantsStarted 2025-09-23

Plain-language summary

A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.

Who can participate

Age range20 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * infertile women Exclusion Criteria: All female patients who will not undergo IVF or whose cycles will be converted to IUI. Male patients will not be enrolled in this study. No donor cycles.

What they're measuring

Total Gonadotropin Dosage

Timeframe: Two weeks after the start of the cycle

Total Oocytes Retrieved

Timeframe: Two weeks after the start of the stimulation cycle

M2 Oocytes

Timeframe: Two weeks after the start of the stimulation cycle

Total Embryos Formed

Timeframe: Two weeks after the start of stimulation cycle

Grade A embryos/Blastocytes

Timeframe: Three weeks after the start of stimulation cycle

Trial details

NCT IDNCT07148999

SponsorUrmila DIwekar

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-02-15

Contact for this trial

Urmila Diwekar, Ph.D.

6308863047 urmila@vri-custom.org

View on ClinicalTrials.gov More Infertility (IVF Patients) trials